Founded in 1999, U.S Stem Cell, Inc. is committed to the development of effective cell technologies to treat a variety of diseases and injuries. By harnessing the body's own healing potential, we may be able to reverse damaged tissue to normal function. U.S. Stem Cell's discoveries include multiple ... Founded in 1999, U.S Stem Cell, Inc. is committed to the development of effective cell technologies to treat a variety of diseases and injuries. By harnessing the body's own healing potential, we may be able to reverse damaged tissue to normal function. U.S. Stem Cell's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle. U.S Stem Cell is focused on regenerative medicine. While most stem cell companies use one particular cell type to treat a variety of diseases, U.S Stem Cell utilizes various cell types to treat different diseases. It is our belief that the unique qualities within the various cell types make them more advantageous to treat a particular disease. Show more
American Premium Water Corp. (HIPH) Distribution in GNC – General Nutrition Center Miami, FL -- March 22, 2018 -- InvestorsHub NewsWire -- EmergingGrowth.com, a leading independent...
After strengthening its balance sheet at the end of last year DryShips, Inc. (NASDAQ: DRYS), a diversified shipping company, planned to rebuild its depleted fleet and they have done exactly that...
Miami, FL -- InvestorsHub NewsWire -- April 12, 2017 -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the...
Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth Miami, FL--(InvestorsHub NewsWire – April 12, 2017) –...
Bioheart Announces Joint Venture in South Africa More Than 51 Million People Will Have Access to Bioheart's Therapies SUNRISE, FL--(Marketwired - Jun 24, 2014) - Bioheart, Inc. (OTCBB:...
Bioheart to Present at the PRP and Regenerative Medicine Symposium (TOBI 2014) SUNRISE, FL--(Marketwired - Jun 4, 2014) - Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the...
AUSTIN, Texas, June 2, 2014 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Bioheart, Inc. (OTCQB:BHRT), a biotechnology company focused on the...
Bioheart to Present at the World Stem Cells & Regenerative Medicine Congress SUNRISE, FL--(Marketwired - May 16, 2014) - Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on...
Bioheart Reports Significant Revenue Increases SUNRISE, FL--(Marketwired - May 15, 2014) - Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and...
Bioheart to Present at 22nd Mediterranean Conference of Medicine and Therapeutic Cosmetic Surgery SUNRISE, FL--(Marketwired - May 13, 2014) - Bioheart, Inc. (OTCQB: BHRT), a biotechnology...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 92500 | 1.0E-6 | CS |
4 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 1535392 | 9.747E-5 | CS |
12 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 596457 | 7.795E-5 | CS |
26 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 461303 | 7.814E-5 | CS |
52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 389153 | 8.055E-5 | CS |
156 | -0.006099 | -99.9836065574 | 0.0061 | 0.0119 | 1.0E-6 | 528054 | 0.00465427 | CS |
260 | -0.003499 | -99.9714285714 | 0.0035 | 0.08715 | 1.0E-6 | 1186956 | 0.02064406 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.